California Life Sciences just released its 2023 sector report, which shows continued growth across the industry as it relates to economic, workforce, diversity, and addresses our resilience in the face of some notable headwinds, including the Inflation Reduction Act. Join CLS executives, Mike Guerra, Marc Fields and Brent Fisk, to discuss the report findings and what keeps California a viable leader in driving innovation, advancing therapies, and improving health outcomes.